MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The neurological manifestations of PHARC syndrome: a systematic review

    V. Mendes Ferreira, M. Magriço, P. Bugalho, B. Meira, R. Barbosa (Lisboa, Portugal)

    Objective: To provide a systematic review of the neurological manifestations of the PHARC syndrome. Background: Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts (PHARC) syndrome…
  • 2023 International Congress

    A single session of aerobic exercise increase EEG gamma band in the motor and sensorimotor areas during usual walking in people with Parkinson’s disease

    D. Orcioli-Silva, R. Vitório, V. Beretta, A. Oliveira, N. Conceição, P. Nóbrega-Sousa, P. Santos, L. Gobbi, J. Barela (Rio Claro, Brazil)

    Objective: We aimed to investigate the effects of a single session of moderate aerobic exercise on electrocortical activity during walking in people with PD. Background:…
  • 2023 International Congress

    Brain functional state mapping in resting state and network alteration in Spinocerebellar Ataxia Type 2 in comparison with healthy controls

    P. Pankaj, S. Kumaran, A. Srivastava, A. Garg, R. Agarwal, A. Nehra (New Delhi, India)

    Objective: The aim of this study is to map the brain functional network alterations by estimating functional connectivity of brain structures in spinocerebellar ataxia type 2.…
  • 2023 International Congress

    Home-based titration with Duodenal infusion of Levodopa in People with Parkinson’s disease: an observational feasibility study

    B. Biering-Sørensen, N. Nielsen, A. Isenberg, L. Olsen, M. Javidi, J. Vilhelmsen, M. Møller, M. Olsen, J. Clausen, T. Thomsen (Glostrup, Denmark)

    Objective: Primary objectives were to assess the feasibility and safety of LCIG home titration with use of telemedicine-assisted (TM) technology, and  patient/caregivers satisfaction. Secondly, to…
  • 2023 International Congress

    Novel application of the Timed Up and Go Scale as a reliable tool to measure functional improvement and fall prevention after inpatient Parkinson’s Disease specific rehabilitation for advanced stages of PD

    M. Mccrossin, L. Rubin, C. Claro, A. Persaud, E. Finlay, A. Sturman, D. Barreto, A. John, M. Tursi, A. Di Rocco (Glen Cove, USA)

    Objective: To determine whether the “Timed Up and Go” (TUG) scale can be effectively utilized in patients with advanced Parkinson’s disease (PD) as an outcome…
  • 2023 International Congress

    Neuropsychiatric Symptoms in Early-Onset Parkinson’s Disease

    C. Piat, E. Camerucci, A. Mullan, K. Ghoniem, J. Jacobson, G. Patanè, P. Turcano, R. Savica (Rochester, USA)

    Objective: To describe the neuropsychiatric symptoms of Early-Onset Parkinson’s Disease (EOPD) patients in an incident cohort study from 1991 to 2010 in Olmsted County, Minnesota…
  • 2023 International Congress

    Comparision of objective Parkinson’s disease monitoring systems and the interpretations of results

    G. Kilincalp, F. Grahn, H. Sabir, D. von Below, A. Jeppsson, A. Sjöström, F. Bergquist (Gothenburg, Sweden)

    Objective: To examine the agreeement between two objective Parkinson’s disease (PD) monitoring systems (PKG and STAT-ON) and clinical information from a resident physician’s interview or…
  • 2023 International Congress

    Use of a wearable vibration-based device for the treatment of Parkinson’s disease tremor

    C. Stephen, E. Fabara, F. Parisi, B. Pugliese, G. Vergara-Diaz, P. Gochyyev, A. Davanzo, D. Carballo, K. Pina, T. Luu, P. Bonato (Boston, USA)

    Objective: To assess the use of a wearable vibration-based device for the treatment of Parkinson’s disease (PD) tremor. Background: PD is a neurodegenerative movement disorder…
  • 2023 International Congress

    Trajectories of Physical Performance in Prodromal and Early Parkinson’s Disease

    M. Bock, K. Covinsky, E. Vittinghoff, C. Tanner, K. Yaffe (San Francisco, USA)

    Objective: To describe trajectories of physical performance in prodromal and early Parkinson’s Disease (PD). Background: There is a need to better characterize the prodromal and…
  • 2023 International Congress

    The Critical Path for Parkinson’s Consortium approach to developing consensus recommendations for neuroimaging biomarkers appropriate for use in Parkinson’s disease drug development

    M. Muller, R. Comley, J. Eberling, H. Kazmi, T. Kustermann, P. Maguire, K. Marek, C. Mcginnity, M. Minchik, C. Parker, L. Passamonti, O. Rousset, D. Russell, C. Salinas, J. Seibyl, S. Sivakumaran, J. Stoessl, A. Strafella, D. Tosun-Turgut, Y. Wang, D. Stephenson, G. Pagano (Tucson, USA)

    Objective: To develop consensus recommendations for neuroimaging biomarkers suitable for use in Parkinson’s disease (PD) drug development. Background: Given the anticipated rise in PD prevalence…
  • « Previous Page
  • 1
  • …
  • 234
  • 235
  • 236
  • 237
  • 238
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley